Jenburkt-Pharma Stock/Share Prices, Buy and Sell Jenburkt-Pharma BSE Stocks

Jenburkt Pharmaceuticals Ltd BSE
Pharmaceuticals, Small Cap

Invest

19 Dec 2018 | 04:01 PM

580.00

2.95 (0.51%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-7.11%

Return (1Y)

Underperformed S&P BSE Sensex by 15.28%
More Volatile

2.44%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 1.65%
Not so consistent

4/12

Months

underperformed S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

880

466

News & Announcements

Jenburkt Pharmaceuticals standalone net profit declines 42.43% in the September 2018 quarter
49 days ago

Jenburkt Pharmaceuticals standalone net profit declines 42.43% in the September 2018 quarter

31 - Oct - 2018 12:00 AM | 49 days ago

Net profit of Jenburkt Pharmaceuticals declined 42.43% to Rs 5.74 crore in the quarter ended September 2018 as against Rs 9.97 crore during the previous quarter ended September 2017. Sales declined 12.98% to Rs 31.98 crore in the quarter ended September 2018 as against Rs 36.75 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 31.98 36.75 -13
OPM % 22.14 33.74 -
PBDT 7.89 13.25 -40
PBT 7.56 12.87 -41
NP 5.74 9.97 -42
Powered by Capital Market - Live News
Jenburkt Pharmaceuticals to declare Quarterly Result
56 days ago

Jenburkt Pharmaceuticals to declare Quarterly Result

24 - Oct - 2018 12:00 AM | 56 days ago

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 October 2018.
Powered by Capital Market - Live News
Jenburkt Pharmaceuticals reports standalone net profit of Rs 2.70 crore in the June 2018 quarter
141 days ago

Jenburkt Pharmaceuticals reports standalone net profit of Rs 2.70 crore in the June 2018 quarter

31 - Jul - 2018 12:00 AM | 141 days ago

Net profit of Jenburkt Pharmaceuticals reported to Rs 2.70 crore in the quarter ended June 2018 as against net loss of Rs 2.88 crore during the previous quarter ended June 2017. Sales rose 36.90% to Rs 23.26 crore in the quarter ended June 2018 as against Rs 16.99 crore during the previous quarter ended June 2017.
Particulars Quarter Ended
Jun. 2018 Jun. 2017 % Var.
Sales 23.26 16.99 37
OPM % 11.18 -21.01 -
PBDT 3.42 -2.55 LP
PBT 3.10 -2.91 LP
NP 2.70 -2.88 LP
Powered by Capital Market - Live News
Jenburkt Pharmaceuticals to conduct board meeting
155 days ago

Jenburkt Pharmaceuticals to conduct board meeting

17 - Jul - 2018 12:00 AM | 155 days ago

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 31 July 2018.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Jenburkt Pharmaceuticals Ltd has increased by 86.49% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	31.98	36.75	-13
OPM %	22.14	33.74	-
PBDT	7.89	13.25	-40
PBT	7.56	12.87	-41
NP	5.74	9.97	-42

Particulars	Quarter Ended
	Jun. 2018	Jun. 2017	% Var.
Sales	23.26	16.99	37
OPM %	11.18	-21.01	-
PBDT	3.42	-2.55	LP
PBT	3.10	-2.91	LP
NP	2.70	-2.88	LP

General Notifications

My Notifications

Research Notifications

Jenburkt Pharmaceuticals Ltd BSE Pharmaceuticals, Small Cap

580.00 2.95 (0.51%)

News & Announcements

Price vs Volume

Stock Trivia

Jenburkt Pharmaceuticals Ltd BSE
Pharmaceuticals, Small Cap

580.00

2.95 (0.51%)